Back to browse

EXP001263

Paper

Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment (2024)

Peptide

Cyc(E4W5ACA) + SA-H8

Sequence: WWWWWEEEEACA + HHHHHHHH

RNA

siRNA

All experiment fields

Experiment Id EXP001263
Paper Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and
Peptide Cyc(E4W5ACA) + SA-H8
Delivery Success Class no
In Vivo Flag no
Uptake Confirmed yes
Label Confidence high
In Vitro Functional Effect yes
Endosomal Escape Evidence yes
Peptide Concentration
Rna Concentration 100 nM
Mixing Ratio SA-H8/siRNA N/P=5:1
Formulation Format Cyc-LH/si (cyclic peptide–modified liposome; SA-H8/siRNA complex encapsulated)
Formulation Components liposome core: DOPE/CHEMS/Chol; PEGylation: DSPE-PEG2000; DSPE-PEG2000-Cyc(E4W5ACA); SA-H8/siPLK-1
Size Nm 150.00
Zeta Mv
Model Scope in_vitro
Model Type in vitro
Cell Lines Or Primary Cells MCF-7; A549
Animal Model
Administration Route
Output Type PLK-1 knockdown / apoptosis
Output Value
Output Units
Output Notes qRT-PCR & western blot show PLK-1 suppression (stronger at pH 6.5); induces apoptosis; pH-responsive uptake and lysosomal escape characterized by confocal/flow cytometry
Toxicity Notes
Curation Notes